94.19
price down icon0.91%   -0.865
 
loading

Insmed Inc (INSM) 最新ニュース

pulisher
Oct 22, 2026

The Escalator: CSL, Insmed, Amgen and more - Medical Marketing and Media

Oct 22, 2026
pulisher
Oct 22, 2026

Insmed names former Sanofi and Novartis CEO Hudson and biopharma exec Koppikar to board - ROI-NJ

Oct 22, 2026
pulisher
Oct 22, 2026

Insmed (INSM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Zacks Investment Research

Oct 22, 2026
pulisher
Oct 22, 2026

Insmed (INSM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance

Oct 22, 2026
pulisher
Oct 20, 2026

Form 4 Insmed Inc: Paul Hudson (Director) For: 19 October By Investing.com - Investing.com Canada

Oct 20, 2026
pulisher
Oct 20, 2026

Utpal Koppikar Appointed to Insmed Board, Reports No Ownership of Company Securities - Kalkine Media

Oct 20, 2026
pulisher
Oct 20, 2026

Insmed Appoints Two New Directors to Its Board - Insmed Incorporated Investor Relations

Oct 20, 2026
pulisher
Oct 20, 2026

Insmed adds two directors with pharma leadership experience - Investing.com

Oct 20, 2026
pulisher
Oct 20, 2026

Insmed appoints Paul Hudson and Utpal Koppikar to its Board - TradingView

Oct 20, 2026
pulisher
Oct 20, 2026

Insmed adds two independent directors with biopharma backgrounds - StreetInsider

Oct 20, 2026
pulisher
Oct 20, 2026

Oral Lung-Disease Tablets: Insmed Brings BRINSUPRI to Japan for NCFB - Trend Hunter

Oct 20, 2026
pulisher
Oct 19, 2026

Insmed launches bronchiectasis treatment in Japan By Investing.com - Investing.com Canada

Oct 19, 2026
pulisher
Oct 19, 2026

Insmed Launches BRINSUPRI® Tablets 25 mg (brensocatib hydrate) for the Treatment of Non-Cystic Fibrosis Bronchiectasis in Japan - Yahoo Finance

Oct 19, 2026
pulisher
Oct 15, 2026

Insmed IncorporatedLaunches Four Pivotal Phase 3 Studies For TPIP In Pulmonary Diseases - TradingView

Oct 15, 2026
pulisher
Oct 15, 2026

Insmed launches four phase 3 trials for lung disease therapy By Investing.com - Investing.com Canada

Oct 15, 2026
pulisher
Oct 15, 2026

Three trials have started for Insmed's inhaled treatment; a fourth is expected in the first half of 2027. - Stock Titan

Oct 15, 2026
pulisher
Oct 14, 2026

Insmed Incorporated (INSM) Options Chain - Yahoo! Finance Canada

Oct 14, 2026
pulisher
Oct 14, 2026

Three presentations will examine an inhaled treatment being studied for high blood pressure in the lungs. - Stock Titan

Oct 14, 2026
pulisher
Oct 14, 2026

A Quick Look at Today's Ratings for Insmed(INSM.US), With a Forecast Between $169 to $220 - Moomoo

Oct 14, 2026
pulisher
Oct 13, 2026

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), ACADIA Pharmaceuticals (ACAD) and Insmed (INSM) - The Globe and Mail

Oct 13, 2026
pulisher
Oct 12, 2026

Insmed Shares Fall After Wolfe Research Downgrade - Yahoo Finance

Oct 12, 2026
pulisher
Oct 12, 2026

Wolfe Research Downgrades Insmed to Peer Perform From Outperform - Moomoo

Oct 12, 2026
pulisher
Oct 12, 2026

Truist previews biotech earnings with focus on Insmed, BridgeBio By Investing.com - Investing.com Canada

Oct 12, 2026
pulisher
Oct 12, 2026

This Insmed Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga

Oct 12, 2026
pulisher
Oct 12, 2026

This Insmed Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga

Oct 12, 2026
pulisher
Oct 12, 2026

BofA cuts Insmed stock price target on valuation concerns By Investing.com - Investing.com India

Oct 12, 2026
pulisher
Oct 12, 2026

Weekly Recap: ARIKAYCE sNDA Jan 28, 2027 FDA date and CFO Bonstein exit - TradingView

Oct 12, 2026
pulisher
Oct 12, 2026

Wolfe Research Downgrades Insmed to Peer Perform From Outperform - Yahoo Finance

Oct 12, 2026
pulisher
Oct 09, 2026

US High Growth Tech Stocks Spotlight Featuring 3 Top Picks - Simply Wall Street

Oct 09, 2026
pulisher
Oct 08, 2026

UBS reiterates Insmed stock rating on Brinsupri sales outlook - Investing.com

Oct 08, 2026
pulisher
Oct 08, 2026

Does Insmed (INSM) CFO Exit With Reaffirmed Guidance Clarify Or Complicate Its Growth Narrative? - Yahoo Finance

Oct 08, 2026
pulisher
Oct 06, 2026

INSM Stock Slides on CFO Exit, Reiterates '26 Sales View - Zacks Investment Research

Oct 06, 2026
pulisher
Oct 06, 2026

INSM Stock Slides on CFO Exit, Reiterates '26 Sales View - TradingView

Oct 06, 2026
pulisher
Oct 06, 2026

Bonstein to step down as Insmed chief financial officer - ROI-NJ

Oct 06, 2026
pulisher
Oct 05, 2026

$100 Invested In Insmed 5 Years Ago Would Be Worth This Much Today - Benzinga

Oct 05, 2026
pulisher
Oct 05, 2026

Insmed Announces CFO Transition - Insmed Incorporated Investor Relations

Oct 05, 2026
pulisher
Oct 05, 2026

Insmed stock falls as CFO Sara Bonstein to step down - Investing.com

Oct 05, 2026
pulisher
Oct 05, 2026

Why is Insmed stock sliding today? By Investing.com - Investing.com India

Oct 05, 2026
pulisher
Oct 05, 2026

Insmed Stock Slides — CFO Exit Date Set, 2026 Guidance Reaffirmed - Benzinga

Oct 05, 2026
pulisher
Oct 05, 2026

Insmed stock falls as CFO Sara Bonstein to step down - Yahoo Finance

Oct 05, 2026
pulisher
Oct 05, 2026

Insmed drops as investors weigh CFO departure despite reaffirmed 2026 outlook - Quiver Quantitative

Oct 05, 2026
pulisher
Oct 05, 2026

Insmed Incorporated Announces Sara Bonstein Steps Down as Chief Financial Officer, Effective October 30, 2026 - marketscreener.com

Oct 05, 2026
pulisher
Oct 05, 2026

Insmed Incorporated Reaffirms Earnings Guidance for the Full-Year 2026 - marketscreener.com

Oct 05, 2026
pulisher
Oct 05, 2026

Insmed Q2 2026 Earnings Call Transcript - Benzinga

Oct 05, 2026
pulisher
Oct 05, 2026

Insmed CFO Sara Bonstein to step down, reaffirms guidance - TradingView

Oct 05, 2026
pulisher
Oct 05, 2026

Insmed CFO Sara Bonstein to step down on October 30 By Investing.com - Investing.com Canada

Oct 05, 2026
pulisher
Oct 05, 2026

Insmed CFO Sara Bonstein to step down Oct 30; c... - pluang.com

Oct 05, 2026
pulisher
Oct 05, 2026

Insmed CFO Sara Bonstein to Separate, Search Underway for Successor - TradingView

Oct 05, 2026
pulisher
Oct 05, 2026

Insmed (INSM) Announces CFO Transition - TradingView

Oct 05, 2026
pulisher
Oct 05, 2026

Insmed Announces CFO Transition - Yahoo Finance

Oct 05, 2026
$89.06
price down icon 0.68%
$116.58
price down icon 0.30%
$39.83
price down icon 0.42%
$65.12
price down icon 0.29%
$241.13
price down icon 0.77%
$36.84
price down icon 1.63%
大文字化:     |  ボリューム (24 時間):